Pentoxifylline inhibits melanoma tumor growth and angiogenesis by targeting STAT3 signaling pathway
Authors:
- Mohammad Zahid KamranMKMohammad Zahid Kamran
- Rajiv P. GudeRGRajiv P. Gude
- 1 June 2013
- journal article
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 67 (5) , 399-405
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Pentoxifylline sensitizes human cervical tumor cells to cisplatin-induced apoptosis by suppressing NF-kappa B and decreased cell senescenceBMC Cancer, 2011
- Interleukin-6 as a Therapeutic Target in Human Ovarian CancerClinical Cancer Research, 2011
- Ptpn11/Shp2 Acts as a Tumor Suppressor in Hepatocellular CarcinogenesisCancer Cell, 2011
- Hypoxia-inducible Factor-1α Enhances Haptoglobin Gene Expression by Improving Binding of STAT3 to the PromoterJournal of Biological Chemistry, 2011
- The small molecule curcumin analog FLLL32 induces apoptosis in melanoma cells via STAT3 inhibition and retains the cellular response to cytokines with anti-tumor activityMolecular Cancer, 2010
- Preclinical Evaluation of an 131I-Labeled Benzamide for Targeted Radiotherapy of Metastatic MelanomaCancer Research, 2010
- The function of Stat3 in tumor cells and their microenvironmentSeminars in Cell & Developmental Biology, 2008
- Vascular Endothelial Growth Factor and AngiogenesisPharmacological Reviews, 2004
- The STATs of cancer — new molecular targets come of ageNature Reviews Cancer, 2004
- Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesisOncogene, 2002